1.Clinical study of Xihuang Pills in treating cyclomastopathy
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(04):-
Objective: To explore the clinical efficacy of Xihuang Pills in treating cyclomastopathy. Methods: Based on inclusion criteria and exclusion criteria, 56 patients with cyclomastopathy were selected, 30 ones in treatment group and take the Xihuang Pills, the other 26 ones were in control group and took Rupixiao Tablets for 3 courses of treatment. Results: The totaleffective rate was 83.33% in the treatment group and that in the control group was 69.22%. The difference between the two groups was statistically significant (P
2.Medication Rules for Hypertension with Preserved Ejection Fraction Heart Failure Based on Data Mining
Jinxuan WEI ; Rong LI ; Suzhen YANG ; Yu WANG ; Rui FAN ; Yanbo SUI
Journal of Medical Informatics 2024;45(1):52-58
Purpose/Significance By using data mining methods,the medication rules and prescription characteristics of traditional Chinese medicine(TCM)for treating hypertension with preserved ejection fraction heart failure are discussed.Method/Process The da-tabase is established based on the TCMprescription information of hypertensive patients with preserved ejection fraction heart failure ad-mitted to the Cardiovascular Disease Department of the First Affiliated Hospital of Heilongjiang University of Chinese Medicine from Janu-ary 2019 to July 2022.SPSS Statistics and Moderler software are used to analyze the frequency,taste,meridian tropism,efficacy,associ-ation rules,clustering and factor analysis of the prescriptions to explore medication rules.Result/Conclusion TCMin the treatment of hy-pertension with preserved ejection fraction heart failure is mainly to replenish qi and spleen,nourish the heart and calm the mind,relieve phlegm,relieve cough and asthma,and pay attention to promoting blood circulation and removing blood stasis,promoting water infiltra-tion and dampness,which can reflect the overall concept of TCMand the characteristics of diagnosis and treatment based on syndrome dif-ferentiation and provide references for clinical medication.